Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Fleming

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Clinical Genitourinary Cancer|July 9, 2013
A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancerAndrew J Armstrong, Tong Shen, Susan Halabi, et al.
The Journal of Allergy and Clinical Immunology|July 7, 2020
ITK deficiency presenting as autoimmune lymphoproliferative syndromeJacqueline G Wallace, Mohammed F Alosaimi, Claudia Djambas Khayat, et al.
Blood|September 20, 2011
A polymorphism in the leptin gene promoter is associated with anemia in patients with HIV diseaseGary J Vanasse, Jee-Yeong Jeong, Janet Tate, et al.
Healthcare Quarterly (Toronto, Ont.)|December 13, 2005
The development of the Canadian paediatric trigger tool for identifying potential adverse eventsAnne Matlow, Virginia Flintoft, Elaine Orrbine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2023
Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate CancerSusan F Slovin, Karen Knudsen, Susan Halabi, et al.
Blood|June 2, 2019
Lack of <i>Gdf11</i> does not improve anemia or prevent the activity of RAP-536 in a mouse model of β-thalassemiaAmaliris Guerra, Paraskevi Rea Oikonomidou, Sayantani Sinha, et al.
The EMBO Journal|September 3, 2004
Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23David MacPherson, Jungho Kim, Teresa Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2002
Telomerase contributes to tumorigenesis by a telomere length-independent mechanismSheila A Stewart, William C Hahn, Benjamin F O'Connor, et al.
Experimental Hematology|February 26, 2005
Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemiaW Nicholas Haining, Angelo A Cardoso, Heather L Keczkemethy, et al.
Muscle & Nerve|September 19, 2024
Neuroma morphology: A macroscopic classification systemFloris V Raasveld, Daniel T Weigel, Wen-Chih Liu, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Clinical Genitourinary Cancer|July 9, 2013
A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancerAndrew J Armstrong, Tong Shen, Susan Halabi, et al.
The Journal of Allergy and Clinical Immunology|July 7, 2020
ITK deficiency presenting as autoimmune lymphoproliferative syndromeJacqueline G Wallace, Mohammed F Alosaimi, Claudia Djambas Khayat, et al.
Blood|September 20, 2011
A polymorphism in the leptin gene promoter is associated with anemia in patients with HIV diseaseGary J Vanasse, Jee-Yeong Jeong, Janet Tate, et al.
Healthcare Quarterly (Toronto, Ont.)|December 13, 2005
The development of the Canadian paediatric trigger tool for identifying potential adverse eventsAnne Matlow, Virginia Flintoft, Elaine Orrbine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2023
Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate CancerSusan F Slovin, Karen Knudsen, Susan Halabi, et al.
Blood|June 2, 2019
Lack of <i>Gdf11</i> does not improve anemia or prevent the activity of RAP-536 in a mouse model of β-thalassemiaAmaliris Guerra, Paraskevi Rea Oikonomidou, Sayantani Sinha, et al.
The EMBO Journal|September 3, 2004
Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23David MacPherson, Jungho Kim, Teresa Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2002
Telomerase contributes to tumorigenesis by a telomere length-independent mechanismSheila A Stewart, William C Hahn, Benjamin F O'Connor, et al.
Experimental Hematology|February 26, 2005
Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemiaW Nicholas Haining, Angelo A Cardoso, Heather L Keczkemethy, et al.
Muscle & Nerve|September 19, 2024
Neuroma morphology: A macroscopic classification systemFloris V Raasveld, Daniel T Weigel, Wen-Chih Liu, et al.
Pageof 10